Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Putter, H."'
Autor:
Dijkstra, E.A., Hospers, G.A.P., Kranenbarg, E.M.K., Fleer, J., Roodvoets, A.G.H., Bahadoer, R.R., Guren, M.G., Tjalma, J.J.J., Putter, H., Crolla, R.M.P.H., Hendriks, M.P., Capdevila, J., Radu, C., Velde, C.J.H. van de, Nilsson, P.J., Glimelius, B., Etten, B. van, Marijnen, C.A.M.
Publikováno v:
Radiotherapy and Oncology, 171, 69-76. ELSEVIER IRELAND LTD
Scientia
Radiotherapy & Oncology, 171, 69-76. ELSEVIER IRELAND LTD
Scientia
Radiotherapy & Oncology, 171, 69-76. ELSEVIER IRELAND LTD
Locally advanced rectal cancer; Quality of life; Total neoadjuvant treatment Cáncer de recto localmente avanzado; Calidad de vida; Tratamiento neoadyuvante total Càncer de recte localment avançat; Qualitat de vida; Tractament neoadjuvant total Bac
Autor:
Boer, S.M. de, Powell, M.E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P.B., Ledermann, J.A., Khaw, P., Colombo, A., Fyles, A., Baron, M.H., Kitchener, H.C., Nijman, H.W., Kruitwagen, R.F., Nout, R.A., Verhoeven-Adema, K.W., Smit, V.T., Putter, H., Creutzberg, C.L., PORTEC Study Grp
Publikováno v:
Lancet oncology, 17(8), 1114-1126. Elsevier Science
The Lancet. Oncology
Lancet Oncology, 17, 8, pp. 1114-26
Lancet Oncology, 17(8), 1114-1126. ELSEVIER SCIENCE INC
The Lancet Oncology, 17(8), 1114-1126
Lancet Oncology, 17, 1114-26
The Lancet. Oncology
Lancet Oncology, 17, 8, pp. 1114-26
Lancet Oncology, 17(8), 1114-1126. ELSEVIER SCIENCE INC
The Lancet Oncology, 17(8), 1114-1126
Lancet Oncology, 17, 1114-26
Contains fulltext : 171831.pdf (Publisher’s version ) (Open Access) BACKGROUND: About 15% of patients with endometrial cancer have high-risk features and are at increased risk of distant metastases and endometrial cancer-related death. We designed
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ina M. Jürgenliemk-Schulz, Ludy C.H.W. Lutgens, Marie Helene Baron, V. Do, Karen W Verhoeven-Adema, C. Post, Nelleke Ottevanger, Carien L. Creutzberg, Christine Haie-Meder, Jonathan A. Ledermann, Susan Brooks, Geraldine Goss, Linda Mileshkin, Anthony Fyles, Paul Bessette, Melanie E Powell, Roldano Fossati, Mary McCormack, Stephanie M. de Boer, Henry C Kitchener, Andrea Lissoni, Alexandra Leary, Vincent T.H.B.M. Smit, Romerai D'Amico, Amanda Feeney, Dionyssios Katsaros, Remi A. Nout, Hans W. Nijman, Hein Putter, Prafull Ghatage, Pearly Khaw
Publikováno v:
International Journal of Radiation Oncology-Biology-Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 975-986
International Journal of Radiation Oncology Biology Physics, 109(4), 975-986. Elsevier Science
International Journal of Radiation Oncology, Biology, Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 4, pp. 975-986
International journal of radiation oncology, biology, physics, 109(4), 975-986. Elsevier
International Journal of Radiation Oncology, Biology, Physics, 109, 975-986
International Journal of Radiation Oncology Biology Physics, 109(4), 975-986. Elsevier Science
International Journal of Radiation Oncology, Biology, Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 4, pp. 975-986
International journal of radiation oncology, biology, physics, 109(4), 975-986. Elsevier
Contains fulltext : 232064.pdf (Publisher’s version ) (Open Access) PURPOSE: The survival results of the PORTEC-3 trial showed a significant improvement in both overall and failure-free survival with chemoradiation therapy versus pelvic radiation t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2798f409593ab83be7f21b7d7f100a58
http://www.redjournal.org/article/S0360301620344473/pdf
http://www.redjournal.org/article/S0360301620344473/pdf